Search

Your search keyword '"Cytarabine metabolism"' showing total 24 results

Search Constraints

Start Over You searched for: Descriptor "Cytarabine metabolism" Remove constraint Descriptor: "Cytarabine metabolism" Journal cancer treatment reports Remove constraint Journal: cancer treatment reports
24 results on '"Cytarabine metabolism"'

Search Results

1. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.

2. Combinations of tetrahydrouridine and cytosine arabinoside in mouse tumors.

Catalog

Books, media, physical & digital resources

3. Double labeling of human leukemic cells using 3H-cytarabine and monoclonal antibody against bromodeoxyuridine.

4. Modulation of cytarabine metabolism in the human promyelocytic leukemia cell line HL-60 by polyhydroxy-substituted benzohydroxamic acids.

5. Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells.

6. Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man.

7. Multivesicular liposomes containing cytarabine for slow-release Sc administration.

8. Modulation of cytarabine uptake and toxicity by dipyridamole.

9. Methotrexate, cytosine arabinoside, and BCNU concentration in brain after ventriculocisternal perfusion.

10. Comparison of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and cytosine arabinoside in the treatment of murine brain tumor.

11. Multivesicular liposomes containing cytarabine entrapped in the presence of hydrochloric acid for intracavitary chemotherapy.

12. Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.

13. Distribution of [3H]cytosine arabinoside and its products in mice, dogs, and monkeys and effect of tetrahydrouridine.

14. Pharmacology and toxicity of high-dose cytarabine by 72-hour continuous infusion.

15. Kinetic and cytotoxic effects of cytarabine and daunorubicin on cells in culture.

16. Effect of the interval between exposures to cytarabine on its cytotoxic action on HL-60 myeloid leukemic cells.

17. Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.

18. Computer simulation of leukemia therapy: combined pharmacokinetics, intracellular enzyme kinetics, and cell kinetics of the treatment of L1210 leukemia by cytosine arabinoside.

19. High-dose cytarabine in acute leukemia: toxicity and pharmacokinetics.

21. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

22. Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes.

23. Physiologic disposition of cytosine arabinoside and its derivatives in man.

24. Potential advances in the clinical use of arabinosyl cytosine.